Archives

by in
Entry Author Date Location
Biotech VCs, in Shadow of Tech, Start Delivering More Hits 07/19/12 National
Amira Pharma on How it Beat the Odds, and Sold an Early Stage Drug to Bristol-Myers for $325M 09/07/11 San Diego
Jennerex Shows that Unorthodox Cancer-Fighting Virus Can be Delivered the Usual Way 08/31/11 San Francisco
Stop the M&A Obsession: Biotech Needs More Companies to Stay Independent 07/18/11 National
Jennerex Shows Survival Edge for Liver Cancer Patients in Small Study of Anti-Tumor Virus 05/19/11 San Francisco
The Resurgence of Gene and Cell Therapy 05/16/11 Seattle
Editor’s Picks: Xconomy Boston’s Top 20 Stories of the First Quarter 03/31/11 Boston
Jennerex, Maker of Cancer-Fighting Virus, Says Early Data Shows Survival Benefit 02/17/11 San Francisco
Clinical Data Stock Soars on FDA Approval, Amgen Buys BioVex, Stromedix Raises $2M, & More Boston-Area Life Sciences News 01/28/11 Boston
Seattle Genetics Manager Accused of Insider Trading, Bristol Stays in Seattle, Amgen Buys BioVex, & More Seattle-Area Life Sciences News 01/27/11 Seattle
Amgen’s R&D Chief, Roger Perlmutter, on Why BioVex’s Cancer-Fighting Virus Is Worth $1B 01/26/11 Boston
Myriant Gets $60M, BioVex Bought By Amgen, Raindance Wraps Up $37.5M, & More Boston-Area Deals News 01/26/11 Boston
Amgen Acquires BioVex for $1,000,000,000 01/25/11 Boston
Amgen to Acquire BioVex for Up To $1B, to Obtain Cancer-Killing Virus Therapy 01/24/11 Boston
Jennerex, Charging Ahead With Tumor-Killing Virus, Follows Biotech Road Less Traveled 09/09/10 San Francisco
2009′s Top 10 Private Equity Deals in Massachusetts: The List 01/25/10 Boston
Bay State Venture Funding Perked Up in November: There Were Even Some Energy Deals 12/11/09 Boston
Pulmatrix Pulls in $30.2M, GenArts Gobbles Up Wondertouch, BioVex Bags $30M, & More Boston-Area Deals News 11/11/09 Boston
BioVex Nails Down Another $30M To Finish Pivotal Study of Cancer-Killing Virus 11/10/09 Boston
BioVex Garners $30,000,000 Series F Funding 11/10/09 Boston
Lilliputian Discovers $25M, Biovex Bags $40M, Clinical Data Cedes Cogenics to Beckman Coulter for $17M, & More Boston-Area Deals News 04/06/09 Boston
Genzyme Shrinks Gene Therapy Effort, Expands Oncology; BioVex Raises $40M For Cancer-Fighting Viruses; Biogen Looks to Future of MS Franchise; & More Boston-Area Life Sciences News 04/01/09 Boston
BioVex Raises $40M for Cancer-Fighting Virus 03/30/09 Boston
Boston Biotechs Seek Scarce Funds Amid Market Famine at Annual Pitch Event 12/04/08 Boston
BioVex Viral Treatment Shrinks Melanoma Tumors in Trial 06/01/08 Boston
Pfizer Picks a Local Target, Sermo Meets Satellite Radio, and the Rest of the Recent Deals 11/19/07 Boston
BioVex Completes $35 Million Financing 11/16/07 Boston
Page 1 of 1

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  2. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Zillions of Biotech Conferences Want You. Which Should You Attend?
  5. Announcing Xconomy Napa Summit 2013: New Rules for Growth

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.